Cargando…

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients

Mostrar otras versiones (1)

Pancreatic cancer is one of the most aggressive gastrointestinal cancer with less than 10% long-term survivors. The apoptotic pathway deregulation is a postulated mechanism of carcinogenesis of this tumour. The present study investigated the prognostic role of apoptosis and apoptosis-involved protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tonini, G, Vincenzi, B, Santini, D, Scarpa, S, Vasaturo, T, Malacrino, C, Coppola, R, Magistrelli, P, Borzomati, D, Baldi, A, Antinori, A, Caricato, M, Nuzzo, G, Picciocchi, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361811/ https://www.ncbi.nlm.nih.gov/pubmed/15928668 http://dx.doi.org/10.1038/sj.bjc.6602632

Ejemplares similares

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients
por: Tonini, G, et al.
Publicado: (2005)

Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
por: Xie, D, et al.
Publicado: (2006)

Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005)

Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome
por: Fangusaro, J R, et al.
Publicado: (2005)

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
por: Lastraioli, E, et al.
Publicado: (2015)

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
por: Brunner, A, et al.
Publicado: (2012)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
por: Hinnis, A R, et al.
Publicado: (2007)

The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
por: Nakano, J, et al.
Publicado: (2008)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion
por: Dallaglio, K, et al.
Publicado: (2014)

Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma
por: Wangsa, D, et al.
Publicado: (2008)

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
por: Burcombe, R J, et al.
Publicado: (2005)

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006)

Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas
por: Torres-Rendon, A, et al.
Publicado: (2009)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma
por: Schrader, C, et al.
Publicado: (2005)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2012)

The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma
por: Klimowicz, A C, et al.
Publicado: (2013)

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
por: Turato, C, et al.
Publicado: (2014)

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
por: Warth, A, et al.
Publicado: (2014)

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
por: Hellman, K, et al.
Publicado: (2014)

KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer–a targeted molecular approach
por: Green, William JF, et al.
Publicado: (2016)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells
por: Hasegawa, H, et al.
Publicado: (2009)

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
por: Xue, A, et al.
Publicado: (2010)

High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction
por: Kikuchi, M, et al.
Publicado: (2009)

Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes
por: Perrone, G., et al.
Publicado: (2010)

Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
por: Kaistha, B P, et al.
Publicado: (2014)

Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study
por: Mukherjee, A, et al.
Publicado: (2005)

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
por: White, N M A, et al.
Publicado: (2014)

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
por: Rogers, A C, et al.
Publicado: (2016)

Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues
por: Lowrie, A G, et al.
Publicado: (2006)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
por: Wallard, M J, et al.
Publicado: (2006)

Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma
por: Schache, A G, et al.
Publicado: (2010)

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
por: Mallett, S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k97k82orb647igs2vj3kg0sojp